Literature DB >> 31045480

Health-Related Quality of Life After Hip Arthroscopy for Femoroacetabular Impingement: A Systematic Review and Meta-analysis.

Chetan Gohal1, Saif Shamshoon2, Muzammil Memon1, Jeffrey Kay1, Nicole Simunovic3, Filippo Randelli4, Olufemi R Ayeni1.   

Abstract

CONTEXT: Hip pain from femoroacetabular impingement (FAI) can impair health-related quality of life (HRQL) but can be treated via hip arthroscopy techniques.
OBJECTIVE: To systematically assess the HRQL outcomes after arthroscopic management of FAI. DATE SOURCES: Three online databases (EMBASE, PubMed, and Ovid [MEDLINE]) were searched for relevant literature from database inception until June 2018 and screened by 2 reviewers independently and in duplicate. STUDY SELECTION: Level I to IV English studies that investigated HRQL outcomes after hip arthroscopy were included. Data for generic and hip-specific HRQL outcomes were collected. Mean differences were plotted in a forest plot when possible. STUDY
DESIGN: Systematic review. LEVEL OF EVIDENCE: Level 4.
RESULTS: A total of 29 studies were included for assessment. Of the 6476 patients (6959 hips), the mean age was 32 years (range 9-79 years) and 50.7% were female. Significant improvements were reported in all studies assessing generic HRQL outcomes, including the 12-Item Short Form Health Survey (range of mean postoperative scores, 82.2-89.8), and EuroQOL-5D scores (range of mean postoperative scores, 0.74-0.87) between 12 and 24 months postoperatively. Significant improvements were similarly identified in the hip-specific HRQL outcomes scores, with the majority of studies also reporting improvement between 12 and 24 months postoperatively. Mean improvement in International Hip Outcome Tool-33 scores from preoperative values to postoperative values ranged from 22.7 to 43.2 ( I2 = 44%), for studies with follow-up between 12 and 24 months.
CONCLUSION: Hip arthroscopy can lead to significant improvement in generic and hip-specific HRQL outcomes at 12 to 24 months postoperatively in patients with FAI who do not have advanced hip osteoarthritis. Confirmatory, high-quality, prospective studies are warranted to compare this observed improvement with other treatment modalities for FAI and to determine long-term outcomes.

Entities:  

Keywords:  FAI; arthroscopy; femoroacetabular impingement; hip; quality of life

Mesh:

Year:  2019        PMID: 31045480      PMCID: PMC6537323          DOI: 10.1177/1941738119838799

Source DB:  PubMed          Journal:  Sports Health        ISSN: 1941-0921            Impact factor:   3.843


  56 in total

1.  Methodological index for non-randomized studies (minors): development and validation of a new instrument.

Authors:  Karem Slim; Emile Nini; Damien Forestier; Fabrice Kwiatkowski; Yves Panis; Jacques Chipponi
Journal:  ANZ J Surg       Date:  2003-09       Impact factor: 1.872

Review 2.  Anterior femoroacetabular impingement: part I. Techniques of joint preserving surgery.

Authors:  Martin Lavigne; Javad Parvizi; Martin Beck; Klaus A Siebenrock; Reinhold Ganz; Michael Leunig
Journal:  Clin Orthop Relat Res       Date:  2004-01       Impact factor: 4.176

Review 3.  A review of femoroacetabular impingement in athletes.

Authors:  Michael J Keogh; Mark E Batt
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

4.  Hip arthroscopy for acetabular labral tears.

Authors:  L A Farjo; J M Glick; T G Sampson
Journal:  Arthroscopy       Date:  1999-03       Impact factor: 4.772

Review 5.  Hip arthroscopy in osteoarthritis. A review of 68 patients.

Authors:  I Helenius; P Tanskanen; J Haapala; R Niskanen; V Remes; R Mokka; O Korkala
Journal:  Ann Chir Gynaecol       Date:  2001

Review 6.  Arthroscopic intervention in early hip disease.

Authors:  Joseph C McCarthy; Jo-Ann Lee
Journal:  Clin Orthop Relat Res       Date:  2004-12       Impact factor: 4.176

7.  Use of the SF-12 instrument for measuring the health of homeless persons.

Authors:  Celia O Larson
Journal:  Health Serv Res       Date:  2002-06       Impact factor: 3.402

Review 8.  Femoroacetabular impingement: a cause for osteoarthritis of the hip.

Authors:  Reinhold Ganz; Javad Parvizi; Martin Beck; Michael Leunig; Hubert Nötzli; Klaus A Siebenrock
Journal:  Clin Orthop Relat Res       Date:  2003-12       Impact factor: 4.176

9.  The Oxford hip score: the patient's perspective.

Authors:  Vikki Wylde; Ian D Learmonth; Victoria J Cavendish
Journal:  Health Qual Life Outcomes       Date:  2005-10-31       Impact factor: 3.186

10.  Hip disability and osteoarthritis outcome score (HOOS)--validity and responsiveness in total hip replacement.

Authors:  Anna K Nilsdotter; L Stefan Lohmander; Maria Klässbo; Ewa M Roos
Journal:  BMC Musculoskelet Disord       Date:  2003-05-30       Impact factor: 2.362

View more
  4 in total

1.  Healing of joint capsule after hip arthroscopy using interportal capsulotomy and capsular closure influences clinical outcomes.

Authors:  Guanying Gao; Chenbo Jiao; Jiayang Liu; Chang Zhou; Yuhao Liu; Yingfang Ao; Yan Xu
Journal:  J Orthop Surg Res       Date:  2022-06-15       Impact factor: 2.677

2.  Variations in postoperative electrolyte concentrations and influential factors in hip arthroscopy.

Authors:  Guanying Gao; Chang Zhou; Yingfang Ao; Jianquan Wang; Yan Xu
Journal:  BMC Musculoskelet Disord       Date:  2022-05-19       Impact factor: 2.562

3.  Changes in Hip Capsule Morphology after Arthroscopic Treatment for Femoroacetabular Impingement Syndrome with Periportal Capsulotomy are Correlated With Improvements in Patient-Reported Outcomes.

Authors:  Kevin H Nguyen; Chace Shaw; Thomas M Link; Sharmila Majumdar; Richard B Souza; Thomas P Vail; Alan L Zhang
Journal:  Arthroscopy       Date:  2021-05-28       Impact factor: 4.772

Review 4.  PRP Is Not Associated With Improved Outcomes Following Hip Femoroacetabular Impingement Surgery: Very Low-Quality Evidence Suggests Hyaluronic Acid and Cell-Based Therapies May Be Beneficial-A Systematic Review of Biological Treatments.

Authors:  Karen Mullins; David Filan; Patrick Carton
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-06-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.